June 2019 | Certara

Poster

Population Pharmacokinetics of Piperacillin-Tazobactam Extended Infusions in Paediatric Population

CertaraJune 24, 2019

Poster

Pharmacodynamics of rituximab on B cells in paediatric post-HSCT patients with EBV

CertaraJune 24, 2019

Poster

Investigating Impacts of Model Parameters Correlations in Global Sensitivity Analysis: Determining the Most Influential Parameters of a Minimal PBPK Model of Midazolam

CertaraJune 24, 2019

Poster

Development and Performance Evaluation of a semi-mechanistic PBPK Model for Topical Ocular Delivery of Pilocarpine and Timolol to Rabbit Eye

CertaraJune 24, 2019

Poster

Transporter inhibition: modelling in-vitro Transwell Assays

CertaraJune 24, 2019

Poster

Development of Paclitaxel PBPK Model to Predict Tumour Concentration in Cancer Patients

CertaraJune 24, 2019

Poster

Mechanistic models of cancer Mechanistic models cancer-immune cycle and immunotherapies

CertaraJune 24, 2019

Poster

Integration of a Tumour Growth Inhibition Model within a Mouse Physiologically-Based Pharmacokinetic Model

CertaraJune 24, 2019

White Paper

Optimize Immuno-oncology Drug Discovery and Development Using QSP

A Quantitative Systems Pharmacology (QSP) approach for developing combination immune-oncology therapies can be used to…

CertaraJune 19, 2019

© 2025 Certara. All Rights Reserved. | Privacy policy